C-RVV

C:RVV - Revive Therapeutics Ltd. - http://www.revivethera.com

14:36:41 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
RVV - C	47.1	0.50	·	0.51	7.0	0.51	+0.05	10.9	3,154.1	1,495	1,303	0.46 0.51 0.445	0.92 0.04	15:59:58	10:42	15 min RT 2¢
CSE - C	47.1	0.50	·	0.51	7.0	0.51	+0.05	10.9	1,818.1	865	648	0.46 0.51 0.445	0.92 0.04	15:59:58		15 min
NEO ATS - U						0.475	+0.015	3.3	569.8	268	209	0.485 0.51 0.45		13:34:13		15 min
Omega - O						0.51	+0.05	10.9	384.0	184	111	0.50 0.51 0.45		15:59:47		15 min
Chi-X - X						0.51	+0.05	10.9	51.7	24	43	0.48 0.51 0.455		15:59:18		15 min
CX2 - H						0.50	+0.04	8.7	319.3	148	252	0.46 0.51 0.45		15:58:14		15 min
CXD - D						0.50	+0.04	8.7	2.1	1	6	0.50 0.50 0.50		09:33:40		15 min
TriAct - M						0.46			9.2	4	34			Sep 08 15:05:25		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Show ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 1303

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:58	C	0.51	0.05	88	7 TD Sec	7 TD Sec	E
15:59:58	C	0.51	0.05	212	7 TD Sec	85 Scotia	E
15:59:58	C	0.51	0.05	4,000	7 TD Sec	7 TD Sec	K
15:59:57	C	0.50	0.04	500	79 CIBC	1 Anonymous	K
15:59:57	C	0.51	0.05	2,000	1 Anonymous	9 BMO Nesbitt	K
15:59:57	C	0.51	0.05	1,000	1 Anonymous	7 TD Sec	K
15:59:57	C	0.51	0.05	1,500	1 Anonymous	7 TD Sec	K
15:59:47	O	0.51	0.05	500	85 Scotia	1 Anonymous	K
15:59:47	C	0.51	0.05	500	85 Scotia	85 Scotia	K
15:59:47	C	0.51	0.05	500	85 Scotia	85 Scotia	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2021-02-26 10:42	C:RVV	0.46	News Release200	Revive Therapeutics to expand bucillamine COVID study
2021-02-26 08:33	C:RVV	0.46	News Release200	Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
2021-02-17 11:09	C:RVV	0.62	News Release200	Revive to acquire psilocybin IP for $10-million
2021-02-12 10:14	C:RVV	0.69	News Release200	Revive closes $23-million prospectus offering
2021-02-11 09:41	C:RVV	0.60	News Release200	Revive talks cannabinoid pharmaceuticals program
2021-02-09 17:06	C:RVV	0.54	News Release200	Revive receives receipt for final prospectus
2021-02-09 15:52	C:RVV	0.53	SEDAR Final Short Form Prospectus810	SEDAR Final Short Form Prospectus
2021-02-08 17:46	C:RVV	0.53	News Release200	Revive Therapeutics files report on Psilocin agreement

Date ET

Symbol

Price

Type

Headline

2021-02-26 10:42

C:RVV

0.46

News Release

Revive Therapeutics to expand bucillamine COVID study

2021-02-26 08:33

C:RVV